none8si13th World Congress on gastrointestinal Cancer of the European Society of Medical Oncology (ESMO), Barcelona, Spain June 2011noneSangro B, Ettorre G, Cianni R, Gasparini D, Golfieri R, Ezziddin S, Kolligs FT, Izzo FSangro B, Ettorre G, Cianni R, Gasparini D, Golfieri R, Ezziddin S, Kolligs FT, Izzo
Radioembolization has emerged as a treatment modality for patients with primary and secondary liver ...
PURPOSE: To determine overall survival (OS), progression-free survival (PFS), and toxicity in patien...
Purpose: To evaluate outcomes of yttrium-90 radioembolization performed with glass-based microsphere...
none8si46° Annual Meeting of the European Association for the study of the liver (EASL) Berlin 30/3-...
none8si23° Annual Congress of the European Association of Nuclear Medicine, Vienna 9-13 oct 2010.non...
none7siAbstract book CIRSE 2010. October 2-6, Valencia, SpainnoneDiaz ML, Bilbao JI, Carpanese L, Ci...
A multicenter analysis was conducted to evaluate the main prognostic factors driving survival after ...
none25siA multicenter analysis was conducted to evaluate the main prognostic factors driving surviva...
OBJECTIVES: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-90 (Y...
none19noBackground:This multi-centre phase II clinical trial is the first prospective evaluation of ...
Using data collected in the prospective observational study CIRSE Registry for SIR-Spheres Therapy, ...
none10no5th European Multidisciplinary colorectal cancer congress (EMCC) Nice 2010 (abstr.p.94).none...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
Purpose: The target lesion response (according to the Choi criteria), safety and survival following ...
Purpose: Although some algorithms are defined for the treatment of advanced hepatocellular carcinoma...
Radioembolization has emerged as a treatment modality for patients with primary and secondary liver ...
PURPOSE: To determine overall survival (OS), progression-free survival (PFS), and toxicity in patien...
Purpose: To evaluate outcomes of yttrium-90 radioembolization performed with glass-based microsphere...
none8si46° Annual Meeting of the European Association for the study of the liver (EASL) Berlin 30/3-...
none8si23° Annual Congress of the European Association of Nuclear Medicine, Vienna 9-13 oct 2010.non...
none7siAbstract book CIRSE 2010. October 2-6, Valencia, SpainnoneDiaz ML, Bilbao JI, Carpanese L, Ci...
A multicenter analysis was conducted to evaluate the main prognostic factors driving survival after ...
none25siA multicenter analysis was conducted to evaluate the main prognostic factors driving surviva...
OBJECTIVES: The aim of this prospective study was to reveal the efficacy and safety of Yttrium-90 (Y...
none19noBackground:This multi-centre phase II clinical trial is the first prospective evaluation of ...
Using data collected in the prospective observational study CIRSE Registry for SIR-Spheres Therapy, ...
none10no5th European Multidisciplinary colorectal cancer congress (EMCC) Nice 2010 (abstr.p.94).none...
The term radioembolization defines those procedures in which intra-arterially injected radioactive m...
Purpose: The target lesion response (according to the Choi criteria), safety and survival following ...
Purpose: Although some algorithms are defined for the treatment of advanced hepatocellular carcinoma...
Radioembolization has emerged as a treatment modality for patients with primary and secondary liver ...
PURPOSE: To determine overall survival (OS), progression-free survival (PFS), and toxicity in patien...
Purpose: To evaluate outcomes of yttrium-90 radioembolization performed with glass-based microsphere...
DOI
Add to ORKG